Keywords = Nanobody
Number of Articles: 6
1. Developing and characterizing a single-domain antibody (nanobody) against human cytotoxic T-lymphocyte-associated protein 4 (hCTLA-4)

Volume 24, Issue 9, September 2021, Pages 1264-1271

Nazli Sotoudeh; Zahra Noormohammadi; Mahdi Habibi-Anbouhi; Fatemeh Kazemi-Lomedasht; Mahdi Behdani


2. Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody

Volume 21, Issue 9, September 2018, Pages 884-888

Farideh Ranjibar; Mahdi Habibi-Anbouhi; Fatemeh Kazemi-Lomedasht; Seyed Hamid Aghaee-Bakhtiyari; Ehsan Alirahimi; Mahdi Behdani


3. Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytes

Volume 21, Issue 5, May 2018, Pages 455-464

Seyed Reza Banihahsemi; Ahmad Zavaran Hosseini; Fatemeh Rahbarizadeh; Davoud Ahmadvand


4. Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function

Volume 21, Issue 3, March 2018, Pages 260-266

Fatemeh Kazemi-Lomedasht; serge muyldermans; Mahdi Habibi-Anbouhi; Mahdi Behdani


5. In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies

Volume 20, Issue 5, May 2017, Pages 489-496

vFatemeh Kazemi-Lomedasht v; Kamran Pooshang-Bagheri; Mahdi Habibi-Anbouhi; Ensiyeh Hajizadeh-Safar; Delavar Shahbazzadeh; Hasan Mirzahosseini; Mahdi Behdani


6. Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)

Volume 19, Issue 11, November 2016, Pages 1201-1208

Vida Homayouni; Mazdak Ganjalikhani-hakemi; Abbas Rezaei; Hossein Khanahmad; Mahdi Behdani; Fatemeh Kazemi Lomedasht